Prevention and treatment of fetal cytomegalovirus infection with cytomegalovirus hyperimmune globulin: a multicenter study in Madrid.
Blázquez-Gamero, Daniel; Galindo Izquierdo, Alberto; Del Rosal, Teresa; Baquero-Artigao, Fernando; Izquierdo Méndez, Nuria; Soriano-Ramos, María; Rojo Conejo, Pablo; González-Tomé, María Isabel; García-Burguillo, Antonio; Pérez Pérez, Noelia; Sánchez, Virginia; Ramos-Amador, Jose Tomás; De la Calle, Maria.
J Matern Fetal Neonatal Med
; 32(4): 617-625, 2019 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-28978246
A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus.
Antenatal interventions for preventing the transmission of cytomegalovirus (CMV) from the mother to fetus during pregnancy and adverse outcomes in the congenitally infected infant.
Control of human viral infections by natural killer cells.
Human cytomegalovirus (HCMV) infection/re-infection: development of a protective HCMV vaccine.
Universal newborn screening for congenital CMV infection: what is the evidence of potential benefit?
Maternal CD4+ T cells protect against severe congenital cytomegalovirus disease in a novel nonhuman primate model of placental cytomegalovirus transmission.
Use of cytomegalovirus hyperimmunoglobulin for prevention of congenital cytomegalovirus disease: a retrospective analysis.
Transfusion-transmitted CMV infection - current knowledge and future perspectives.
Advancing Our Understanding of Protective Maternal Immunity as a Guide for Development of Vaccines To Reduce Congenital Cytomegalovirus Infections.
Cytomegalovirus viral load in cord blood and impact of congenital infection on markers of hematopoietic progenitor cell potency.